The cannabis market is undergoing a seismic shift. While Delta-9 THC has long been the king, a new contender has emerged: legal hemp-derived Delta-9 THC. And alongside it, THCA is rising in prominence. How do these cannabinoids compare, and what opportunities do they present for your business?
As a cannabis entrepreneur, understanding the nuances of THCA (tetrahydrocannabinolic acid) and both forms of Delta-9 THC (delta-9-tetrahydrocannabinol) – cannabis-derived and hemp-derived – is paramount. These compounds are shaping the future of the cannabis industry, presenting a labyrinth of possibilities and challenges for cannabis businesses.
THCA (tetrahydrocannabinolic acid) is a non-psychoactive cannabinoid found in raw cannabis. Delta-9 THC (delta-9-tetrahydrocannabinol) is the main psychoactive compound that causes the “high.”
THCA converts to Delta-9 THC when heated. Hemp-derived Delta-9 THC is federally legal if the final product contains less than 0.3% Delta-9 THC by dry weight.
The game changed substantially with the passage of the 2018 Farm Bill. This legislation carved out a legal pathway for hemp-derived Delta-9 THC products, effectively creating a booming new market segment within the broader cannabis landscape. For instance, in states without legalized cannabis, customers can visit their local retailer and purchase hemp-derived Delta-9 THC chocolates, beverages, and more. This has created significant opportunities for hemp growers and product manufacturers, including companies like us, CBD Nationwide.
Table of Contents
ToggleTHCA and Delta-9 THC: Understanding the Basics
Before we navigate the complexities of their legal status and market potential, let’s establish a foundational understanding of what THCA and Delta-9 THC truly are. As you likely know, these compounds, along with CBD, are among the most prevalent of the hundreds of cannabinoids found within the cannabis plant. We at CBD Nationwide have spent years working with these substances and researching their properties, and we’ve come to appreciate their unique complexities.
What Are They?
THCA, or tetrahydrocannabinolic acid, is the non-intoxicating acidic precursor to Delta-9 THC. Imagine it as the raw, unrefined version found in abundance in raw cannabis. Fresh cannabis, in fact, typically contains high concentrations of THCA. Delta-9 THC, on the other hand, is widely recognized as the primary psychoactive component of cannabis. It’s the compound responsible for the “high” that draws many people to cannabis products.
Crucially, we must differentiate between two forms of Delta-9 THC:
- Cannabis-derived Delta-9 THC: This is the traditional form extracted from marijuana plants. It remains federally illegal as a Schedule I controlled substance.
- Hemp-derived Delta-9 THC: This form is extracted from hemp plants, which are defined as cannabis plants containing less than 0.3% Delta-9 THC by dry weight. Under the 2018 Farm Bill, this form is legal when within the specified limits.
When THCA is heated through processes like smoking, vaping, or cooking, it undergoes a transformation known as decarboxylation, converting into the psychoactive Delta-9 THC. This conversion also occurs naturally over time, as a cannabis plant is exposed to sunlight and oxygen. THCA was first identified in 1965, and scientists have been studying it ever since.
Chemical Structures
The chemical structures of THCA and Delta-9 THC are remarkably similar, with one key difference: a carboxyl group. THCA possesses this extra carboxyl group, which is removed during the decarboxylation process to create Delta-9 THC. The presence or absence of this seemingly small structural feature dictates their psychoactivity – or lack thereof.
Because this conversion occurs during decarboxylation, five milligrams of THCA will only yield 4.4 milligrams of Delta-9 THC. In other words, THC weighs 87.7% of THCA.
Effects on the Body
The effects of THCA and Delta-9 THC on the body differ significantly due to their distinct chemical structures and interaction with the endocannabinoid system.
THCA:
- Non-intoxicating: As mentioned, THCA does not produce the “high” associated with Delta-9 THC.
- Potential Therapeutic Properties: Preclinical studies, primarily conducted on mice, suggest that THCA may offer a range of therapeutic benefits. These include potential anti-inflammatory, neuroprotective, and antiemetic properties.
- For instance, some studies on mice have revealed that THCA may lower proteins linked to Alzheimer’s disease and improve cognitive function.
- Other research indicates THCA could improve symptoms of metabolic syndrome or even help with weight loss.
- A Different Kind of Relief: In essence, THCA may offer a unique avenue for experiencing the therapeutic potential of cannabis without the intoxicating effects.
Delta-9 THC (both forms):
- Psychoactive: Delta-9 THC is renowned for its psychoactive properties, producing the characteristic cannabis “high.” This can manifest as euphoria, relaxation, altered sensory perception, increased appetite, and pain relief.
- Anxiety Modulation: It’s worth noting that Delta-9 THC can have a dual effect on anxiety, reducing it in some individuals while potentially increasing it in others. This variability underscores the complex and individualized nature of cannabinoid interactions.
- The Most Studied Cannabinoid: Delta-9 THC is the most extensively studied cannabinoid, with a wealth of research exploring its effects, both positive and negative.
- Potential Side Effects: While recreational use of Delta-9 THC can be enjoyable for many, it’s important to acknowledge potential negative side effects such as anxiety, paranoia, impaired coordination, and memory problems. Furthermore, Delta-9 THC has the potential to be addictive.
Production: From Plant to Product
Having explored the fundamental differences between THCA and Delta-9 THC, let’s now examine how these cannabinoids are brought to market, from cultivation in the field to the diverse range of products available to consumers. Whether it’s the careful nurturing of cannabis plants or the precise extraction and processing techniques, each stage plays a crucial role in shaping the final product.
Cultivation
The journey begins with cultivation, where growers employ a variety of techniques to influence the cannabinoid content of their plants. Think of it like a conductor leading an orchestra, with each instrument representing factors like light cycles, nutrient levels, and harvesting time. By meticulously adjusting these elements, cultivators can guide the plant to produce higher concentrations of either THCA or Delta-9 THC.
- Fine-Tuning Cannabinoid Levels: Growers can manipulate factors like light, nutrients, and harvest time to influence THCA and Delta-9 THC levels. Earlier harvests typically result in higher THCA content, as the plant hasn’t had as much time to convert THCA into Delta-9 THC naturally.
- Specialized Strains: Just as breeders have developed countless varieties of apples, each with its unique flavor profile, cannabis breeders have created specialized strains designed to maximize either THCA or Delta-9 THC production.
- Hemp-Specific Considerations: For hemp cultivation aimed at Delta-9 THC extraction, the focus shifts to maximizing overall cannabinoid content while meticulously staying within the legal limit of 0.3% Delta-9 THC by dry weight. This requires careful strain selection and precise harvesting practices.
Extraction and Processing
Once the plants have reached their peak cannabinoid potential, the next step is extraction and processing. This is where the raw plant material is transformed into the refined products consumers seek.
- Extraction Methods: Cannabinoid extraction from cannabis involves various methods, broadly categorized as solvent-based or solventless.
- Solvent-based: These methods utilize solvents like ethanol, butane, or CO2 to dissolve and separate the desired cannabinoids from the plant material. Each solvent has its advantages and drawbacks in terms of efficiency, safety, and the resulting product’s purity.
- Solventless: Techniques like ice water hash and rosin pressing rely on physical separation methods, using cold temperatures or pressure to extract cannabinoids without the need for solvents. These methods are often favored for their purity and preservation of the plant’s natural terpene profile.
- THCA Isolation: THCA can be isolated in a crystalline form, often referred to as THCA diamonds. These diamonds have become a popular product for dabbing, offering a potent and flavorful experience. They can also be added to marijuana to increase THC levels.
- Hemp-Derived Delta-9 THC Challenges:
- Producers of hemp-derived Delta-9 THC face unique challenges, primarily the need to extract Delta-9 THC while complying with the stringent 0.3% limit. This often involves sophisticated extraction and purification techniques.
- Adding to the complexity, some states prohibit the use of synthesized cannabinoids in hemp products. This creates further hurdles and increases production costs, as it limits the available extraction methods.
- The Heat Problem: Producing THCA-rich hemp products is particularly challenging because the manufacturing process typically involves heat, which, as we know, converts THCA to Delta-9 THC. Thus, manufacturers must employ specialized techniques to minimize this conversion and preserve the desired THCA content.
Common Product Forms
The extracted and processed cannabinoids are then formulated into a wide array of products, catering to diverse consumer preferences.
- THCA: You’ll find THCA in its raw form, such as raw cannabis flower, as well as in tinctures, capsules, topicals, and even patches (similar to nicotine patches). THCA diamonds, as mentioned earlier, are another popular option.
- Delta-9 THC (both forms): The product landscape for Delta-9 THC is vast. It includes traditional forms like flower, as well as a plethora of edibles (gummies, chocolates, beverages), concentrates (shatter, wax, oil), tinctures, topicals, capsules, and powders. There truly is a Delta-9 THC product for everyone.
- Hemp-Derived Delta-9 THC Focus: Due to the legal requirement of maintaining low Delta-9 THC concentrations, edibles, especially gummies, have become particularly prevalent in the hemp-derived market. They allow for precise dosage control, making it easier to stay within legal limits. For example, a company may make Delta 9 THC Chocolate Bars that contain 0.3% Delta-9 THC.
- THCA and the Standard THC Experience: It’s important to note that vaping or smoking THCA products will convert the THCA to THC, providing a standard THC experience.
- Market Availability: In states where marijuana is legal, consumers will generally find a wider selection of Delta-9 THC products compared to THCA products derived from hemp.
- Care and Patience: Creating high-THCA hemp products without exceeding the 0.3% Delta-9 THC limit requires significant care, expertise, and patience from manufacturers.
Legal Status: Navigating the Maze – A Deep Dive
If you’re a cannabis entrepreneur, you understand that the legal landscape surrounding cannabinoids is complex and constantly evolving. This is especially true for hemp-derived Delta-9 THC, a segment that has experienced explosive growth—and scrutiny—since the passage of the 2018 Farm Bill. Let’s dissect this intricate legal framework, examining federal regulations, state-level variations, and the implications for your business.
The 2018 Farm Bill: The Game Changer
At the heart of the hemp-derived Delta-9 THC boom lies the 2018 Farm Bill. This landmark legislation fundamentally altered the legal status of hemp, defining it as cannabis with less than 0.3% Delta-9 THC by dry weight and removing it from the purview of the Controlled Substances Act. Importantly, the bill also legalized all derivatives of hemp, paving the way for the surge in hemp-derived Delta-9 THC products we see today.
Delta-9 THC: Cannabis vs. Hemp
Understanding the distinction between cannabis-derived and hemp-derived Delta-9 THC is crucial from a legal standpoint.
- Cannabis-derived Delta-9 THC: This form remains federally illegal, classified as a Schedule I controlled substance. While many states have legalized it for medical and/or recreational use, the regulations vary widely, creating a patchwork of differing laws across the country.
- Hemp-derived Delta-9 THC: This is where things get interesting. Hemp-derived Delta-9 THC is legal under the 2018 Farm Bill, but with two key conditions:
- It must be derived from legally cultivated hemp, meaning cannabis plants containing less than 0.3% Delta-9 THC by dry weight.
- The final product, regardless of its form, must contain no more than 0.3% Delta-9 THC by dry weight.
The Ninth Circuit Case
A pivotal legal development further solidified the argument for the legality of hemp-derived Delta-9 THC. In the case of AK Futures LLC v. Boyd Street Distro, LLC, the Ninth Circuit Court of Appeals ruled that Delta-8 THC products derived from legal hemp were not illegal under the Controlled Substances Act. While the case specifically addressed Delta-8 THC, many legal experts believe that the same reasoning could be applied to hemp-derived Delta-9 THC, bolstering its legal standing.
Federal Regulator Actions
Federal regulators are split on how to deal with intoxicating hemp products.
- The FDA has taken the position that it considers any cannabinoid added to food to be an adulterant. However, the agency has largely limited its enforcement actions to companies making medical claims about their products.
- The DEA has maintained that any naturally-present cannabinoid in hemp is legal, but any synthetically-created cannabinoid violates the CSA. There are rumors that the DEA may propose new regulations for intoxicating hemp products.
State Regulations: A Patchwork
While the 2018 Farm Bill sets the federal framework, states have the authority to regulate hemp and its derivatives more stringently. This has resulted in a diverse and often confusing patchwork of state-level regulations concerning hemp-derived Delta-9 THC. Here are five main approaches states have taken:
- Banning All: Some states, including Idaho, Hawaii, Massachusetts, and Washington, have implemented policies that either ban products exceeding 0.3% total Delta-9 THC or prohibit the sale of food and beverages containing any adulterants as determined by the FDA. Despite these policies, hemp-derived Delta-9 THC products are still available in Massachusetts and Washington.
- Banning Synthesized Cannabinoids: States like California, Arkansas, and Connecticut have taken a different approach, excluding synthesized cannabinoids from their definition of hemp. This effectively outlaws Delta-9 THC produced through the conversion of CBD. However, products containing Delta-9 THC synthesized from CBD continue to be sold in these states.
- Regulating Hemp Like Cannabis: Vermont has chosen to treat hemp products containing more than 1 milligram of Delta-9 THC as cannabis, subjecting them to the same regulations and licensing requirements as marijuana products. This effectively restricts their sale to licensed dispensaries. Missouri is currently considering a similar measure.
- Restricting to Very Low Doses: New York, Connecticut, and Colorado have established low limits on the amount of Delta-9 THC allowed per serving or container in hemp products. These limits typically range from 1 milligram to 5 milligrams per serving. Florida may also take this approach in the future.
- Establishing a Unique Hemp Regulatory System: Louisiana, Minnesota, and Utah have created unique regulatory frameworks specifically for hemp-derived products. These systems permit the production and sale of hemp-derived foods and beverages with specific THC limits (ranging from 5 milligrams to 8 milligrams per serving) and impose testing and labeling requirements. South Carolina may consider this approach.
THCA: A Different Legal Landscape
In contrast to Delta-9 THC, THCA, being non-intoxicating, generally faces fewer regulatory hurdles. Its legal status is primarily tied to the 2018 Farm Bill’s definition of hemp, which encompasses all cannabinoids derived from hemp, as long as the final product contains less than 0.3% Delta-9 THC by dry weight. However, some states have implemented regulations based on “total THC” content, which can include THCA, adding another layer of complexity.
California’s Assembly Bill 2223
California Assembly Bill 2223, introduced on February 7, 2024, proposes a novel hybrid approach to regulating hemp products, including a ban on synthesized cannabinoids. If passed, AB 2223 would have several significant implications:
- It would allow cannabis operators to purchase hemp or hemp derivatives from licensed hemp producers for use in cannabis products.
- It would prohibit cannabis operators from using synthesized cannabinoids in their products, even when utilizing hemp.
- The bill offers a more detailed definition of “synthetically derived cannabinoids,” which would apply to both the cannabis and hemp industries.
- AB 2223 would cap the serving size of cannabinoid-containing hemp products at five servings per package and establish a yet-to-be-determined THC limit for hemp products.
Business Implications
For businesses operating in the hemp-derived Delta-9 THC space, understanding and complying with both federal and state regulations is not just a matter of legal obligation—it’s crucial for survival.
- Navigating Complexity: The complex and often conflicting web of regulations can be challenging to navigate, requiring businesses to stay informed and adapt quickly to changes.
- Potential Legal Risks: Non-compliance can lead to significant legal risks, including enforcement actions, product recalls, and hefty fines.
- The Reality of Online Sales: It’s worth noting that many online sellers of hemp-derived Delta-9 THC products currently ship to states across the country, often regardless of individual state regulations. This practice highlights the tension between federal and state laws and the challenges of enforcement in the rapidly evolving digital marketplace.
The Future of Hemp-Derived Delta-9 THC
Hemp-derived Delta-9 THC is currently legally available in more states than adult-use cannabis. These products are popular with both hemp farmers and consumers, and it may not be practical to ban them entirely.
There is opposition to these products, however, from anti-cannabis activists concerned about minors and state-licensed cannabis operators concerned about the economic advantage of hemp producers. Governmental action on the legality of cannabis, such as DEA rescheduling, would likely reduce the incentives for cannabis operators to lobby against hemp. The largest potential threat to hemp-derived Delta-9 products is the upcoming reauthorization of the Farm Bill.
Market Potential and Consumer Trends
Beyond the legal intricacies, the market potential for THCA and both forms of Delta-9 THC is substantial, driven by evolving consumer preferences and a growing interest in the diverse benefits of cannabinoids. As a business operating in this space, understanding these trends is key to developing successful products and capturing market share.
THCA
The market for THCA is on an upward trajectory, fueled by increasing interest in non-intoxicating cannabinoids for potential health and wellness benefits.
- Target Audience: THCA appeals to a specific segment of consumers – those seeking the potential therapeutic effects of cannabis without the “high” associated with Delta-9 THC. This includes individuals looking for natural alternatives for managing various conditions or simply incorporating wellness-focused products into their routines.
- Product Potential: The market potential for THCA lies in products that highlight its unique properties, such as wellness-focused formulations, topical applications, and raw cannabis products that preserve the natural THCA content.
Delta-9 THC
The Delta-9 THC market can be segmented into two distinct categories: cannabis-derived and hemp-derived, each with its own market dynamics.
- Cannabis-Derived: This is the established market, encompassing both recreational and medical use in states with legal frameworks. Demand remains strong for a wide range of product forms, potencies, and terpene profiles, catering to diverse consumer preferences. Growth is expected to continue as more states legalize cannabis and markets mature.
- Hemp-Derived: The hemp-derived Delta-9 THC market is experiencing rapid growth, driven by a unique combination of factors: legality, accessibility, and affordability.
- A Wider Reach: Its legal status under the 2018 Farm Bill allows it to reach consumers in states without legal cannabis, effectively expanding the market’s geographic footprint.
- Lower Price Point: Hemp-derived Delta-9 THC products are often more affordable than their cannabis-derived counterparts, making them attractive to a broader range of consumers.
- A Niche Market: This segment is particularly popular in states without legal cannabis, where it offers a legal alternative for consumers seeking THC’s effects.
Business Opportunities
The evolving landscape presents a wealth of opportunities for businesses to innovate, differentiate their product lines, and establish a strong presence in the market.
- Unique Selling Propositions: Both THCA and the two types of Delta-9 THC offer unique selling propositions that businesses can leverage. Whether it’s the non-intoxicating nature of THCA or the specific legal status and accessibility of hemp-derived Delta-9 THC, companies can tailor their marketing and product development to highlight these advantages.
- Hemp-Derived Delta-9 THC:
- Market Entry: Hemp-derived Delta-9 THC presents a significant opportunity for businesses to enter the cannabinoid market with legally compliant products, especially in states without established cannabis markets.
- Reaching New Consumers: The broader legal reach of hemp-derived Delta-9 THC allows businesses to tap into a wider consumer base, including those residing in states without legal cannabis.
- Lower Barriers: Compared to the heavily regulated cannabis market, the hemp-derived Delta-9 THC space generally has lower barriers to entry, although navigating the complex regulatory landscape remains crucial.
- IRS Section 280E: Hemp-derived Delta-9 THC businesses can avoid the negative impacts of IRS Section 280E, which currently applies to cannabis-derived Delta-9 THC businesses.
- THCA: Increased demand for THCA products could be significant, as health-conscious consumers are always looking for new products.
- Future Growth: Both THCA and Delta-9 THC have significant market potential as the cannabis market continues to grow and mature.
Benefits and Risks: A Summary
As we’ve seen, THCA and both forms of Delta-9 THC offer a complex interplay of potential benefits and risks. Understanding this duality is crucial for both consumers and businesses navigating the cannabinoid landscape. Let’s summarize the key considerations for each.
THCA
- Benefits:
- Potential Therapeutic Effects: Research, particularly preclinical studies, suggests that THCA may offer anti-inflammatory, neuroprotective, and antiemetic properties. These findings, while preliminary, point towards exciting possibilities for THCA in various therapeutic applications.
- Non-Intoxicating: Perhaps the most significant benefit of THCA is its non-intoxicating nature. This allows individuals to potentially experience the therapeutic benefits of cannabis without the psychoactive effects associated with Delta-9 THC.
- Risks:
- Unregulated Products: The lack of comprehensive regulation in the THCA market can lead to inconsistencies in product quality and potency. There’s also a risk of contamination, as highlighted by a 2022 report that evaluated 53 samples of hemp and found that 49 of them had higher amounts of THCA than is allowed to be sold as hemp.
- Unknown Long-Term Effects: As with any relatively new compound, the long-term effects of THCA consumption are not yet fully understood. Further research is needed to establish a comprehensive safety profile.
- Drug Testing Issues: Even though THCA is non-intoxicating, its consumption could potentially lead to issues with drug testing, as some tests may not differentiate between THCA and THC.
- Extraction and Processing: The extraction and processing of THCA can involve the use of solvents or other chemicals that may pose health risks if not properly removed from the final product.
- Dosage: The concentration of THCA can vary significantly between products, making it difficult to determine the appropriate dosage.
- Side Effects: Consuming THCA can lead to nausea, upset stomach, itching, rashes, or respiratory symptoms.
- Drug Interactions: THCA may interact with prescription medications.
Delta-9 THC (Both Forms)
- Benefits:
- Proven Efficacy: Delta-9 THC has a well-established track record in providing pain relief, reducing nausea, stimulating appetite, and offering anxiety and stress reduction for some individuals.
- Muscle Relaxant: It also exhibits muscle relaxant properties, which can be beneficial for individuals with certain medical conditions.
- Risks:
- Psychoactive Effects: The very nature of Delta-9 THC as a psychoactive compound carries inherent risks, including the potential for anxiety, paranoia, and impaired cognitive and motor functions.
- Potential for Addiction: Delta-9 THC has the potential for addiction, particularly with regular use.
- Mental Health Effects: Chronic use of Delta-9 THC, especially in adolescents, has been linked to potential long-term mental health effects.
- Lung Health: Smoking any chemical, including Delta-9 THC, can have negative impacts on lung health.
Comparison Table: THCA vs. Delta-9 THC
To further clarify the distinctions between THCA and both forms of Delta-9 THC, let’s present a concise comparison table summarizing their key features:
Feature | THCA | Delta-9 THC (Cannabis-Derived) | Delta-9 THC (Hemp-Derived) |
---|---|---|---|
Psychoactivity | Non-psychoactive | Psychoactive | Psychoactive |
Chemical Structure | Contains a carboxyl group | Lacks a carboxyl group | Lacks a carboxyl group |
Stability | Less stable | More stable | More stable |
Effects | Potential anti-inflammatory, neuroprotective, antiemetic | Euphoria, relaxation, pain relief, increased appetite | Same as cannabis-derived, but often in lower doses |
Legal Status (US) | Generally legal under 2018 Farm Bill (hemp-derived, <0.3% Delta-9 THC) | Federally illegal (Schedule I controlled substance) | Legal under 2018 Farm Bill if <0.3% by dry weight in final product |
Common Forms | Raw flower, tinctures, capsules, diamonds, patches | Flower, edibles, concentrates, tinctures, topicals, capsules, powders | Primarily edibles (gummies), but also tinctures, beverages |
Source | Hemp or cannabis | Primarily cannabis | Hemp |
Conclusion
As we conclude our exploration of THCA and the two forms of Delta-9 THC, it’s evident that these cannabinoids represent a dynamic and evolving frontier in the cannabis industry. Each offers a unique profile of properties, effects, production methods, and legal considerations, presenting both opportunities and challenges for businesses and consumers alike.
Key Differences
Let’s briefly recap the fundamental distinctions:
- THCA: The non-intoxicating precursor to Delta-9 THC, found in raw cannabis, with potential therapeutic benefits that are generating growing interest.
- Delta-9 THC (Cannabis-Derived): The well-known psychoactive component of cannabis, federally illegal but legal for medical or recreational use in many states, offering a wide range of established product forms.
- Delta-9 THC (Hemp-Derived): A legal alternative under the 2018 Farm Bill when derived from hemp and within the 0.3% Delta-9 THC limit, creating a rapidly expanding market segment with unique accessibility and affordability.
The Importance of Hemp-Derived Delta-9
Hemp-derived Delta-9 THC, in particular, represents a significant market opportunity and a major shift in the cannabis industry. Its legal status has opened doors for businesses to reach a wider consumer base, particularly in states without legal cannabis, and has fueled innovation in product development.
Informed Decision-Making
For businesses, this information is crucial for making informed decisions. Whether you’re a grower, processor, manufacturer, or retailer, understanding the nuances of these cannabinoids is essential for:
- Product Development: Creating products that meet consumer demand and comply with the complex regulatory landscape.
- Marketing: Effectively communicating the unique selling propositions of your products and targeting the right consumer segments.
- Navigating the Legal Landscape: Staying informed about federal and state regulations, ensuring compliance, and mitigating potential legal risks.
A Forward-Looking Perspective
The story of THCA, Delta-9 THC, and the cannabis market as a whole is far from over. Ongoing research continues to uncover new insights into the properties and potential applications of these cannabinoids. The legal landscape remains fluid, with ongoing discussions and potential changes at both the federal and state levels.
As the cannabis industry continues to evolve, one thing is certain: THCA and both forms of Delta-9 THC will undoubtedly play significant roles in shaping its future. By staying informed, adapting to change, and embracing innovation, businesses can position themselves to thrive in this dynamic and exciting market. Here at CBD Nationwide, we’re excited to be a part of this journey, and we look forward to seeing what the future holds for these remarkable compounds.